CORC

浏览/检索结果: 共8条,第1-8条 帮助

已选(0)清除 条数/页:   排序方式:
Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy 期刊论文
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 卷号: 47, 期号: 2
作者:  Zhao, Yinghao;  Yang, Wei;  Huang, Yuanyuan;  Cui, Ranji;  Li, Xiangyan
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 卷号: 6
作者:  Wu, Bin;  Zhang, Qiang;  Sun, Jie
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma 期刊论文
Journal for immunotherapy of cancer, 2018, 卷号: 6, 页码: 124
作者:  Wu Bin[1];  Zhang Qiang[2];  Sun Jie[3]
收藏  |  浏览/下载:1/0  |  提交时间:2019/04/22
Comparisons of therapeutic efficacy and safety of ipilimumab plus GM-CSF versus ipilimumab alone in patients with cancer: a meta-analysis of outcomes 期刊论文
DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 卷号: 12
作者:  Chen, Peng;  Chen, Fuchao;  Zhou, Benhong
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases 期刊论文
BMC CANCER, 2018, 卷号: Vol.18
作者:  Surabhi Ranjan;  Martha Quezado;  Nancy Garren;  Lisa Boris;  Christine Siegel
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/26
Primary adrenal malignant melanoma: A case report and review of literature 期刊论文
MEDICINE, 2017, 卷号: 96, 期号: 51
作者:  Jin, Meishan;  Li, Mingyang;  Xu, Bo;  Wang, Chunxi;  Wang, Xiaoqing
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Risk of treatment-related mortality in cancer patients treated with ipilimumab: A systematic review and meta-analysis 期刊论文
EUROPEAN JOURNAL OF CANCER, 2017, 卷号: 83
作者:  Zhang, Sheng;  Liang, Fei;  Li, Wenfeng;  Wang, Qing
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Novel anti-melanoma treatment: focus on immunotherapy 期刊论文
CHINESE JOURNAL OF CANCER, 2014, 卷号: 33
作者:  Hao MengZe;  Zhou WenYa;  Du XiaoLing;  Chen KeXin;  Wang GuoWen
收藏  |  浏览/下载:19/0  |  提交时间:2020/12/28


©版权所有 ©2017 CSpace - Powered by CSpace